Re: Virgin buys 23andMe #announcements


JoAnne Goldberg
 

Since the beginning, 23andMe has made no secret of the fact that their
primary goal is partnering with biotech/bigpharma to discover targeted
therapies. (They are a local company for me, and I have had these
conversations with two of their senior scientists -- people I know
through other connections.)

Fact is, that collecting ~$100 to analyze DNA and provide customers with
ongoing access to the platform was never going to be a viable long-term
business model. If not for 80% of their customers opting to share data,
the company would be in much worse shape.
--
JoAnne Goldberg - Menlo Park, California; GEDmatch M131535
BLOCH, SEGAL, FRIDMAN, KAMINSKY, PLOTNIK/KIN -- LIthuania
GOLDSCHMIDT, HAMMERSCHLAG,HEILBRUNN, REIS(S), EDELMUTH, ROTHSCHILD, SPEI(Y)ER -- Hesse, Germany
COHEN, KAMP, HARFF, FLECK, FRÖHLICH, HAUSMANN,  DANIEL  -- Rhineland, Germany

 

Join main@groups.jewishgen.org to automatically receive all group messages.